Cellectis S.A. (CLLS) stock
CLLSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.06+0.02 (+1.92%)
Close on Nov 17, 2026Market cap $106.36MP/E –Yield –
Cellectis market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Cellectis's market cap was $138.96M on Nov 11, 2026, against $508.65M a year earlier. Over the last 5 years it ranged from $53.92M to $508.65M, with a median of $161.15M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $138.96M | -71.4% |
| 2025 | Dec 31, 2025 | $485.57M | +169.5% |
| 2024 | Dec 31, 2024 | $180.17M | +28.4% |
| 2023 | Dec 29, 2023 | $140.29M | +46.8% |
| 2022 | Dec 30, 2022 | $95.57M | -74.1% |
| 2021 | Dec 31, 2021 | $369.15M | -67.9% |
| 2020 | Dec 31, 2020 | $1.15B | +58.3% |
| 2019 | Dec 31, 2019 | $726.40M | +21.3% |
| 2018 | Dec 31, 2018 | $598.74M | -41.9% |
| 2017 | Dec 29, 2017 | $1.03B | +72.7% |
| 2016 | Dec 30, 2016 | $596.28M | -34.7% |
| 2015 | Dec 31, 2015 | $913.73M | – |
See a number that looks wrong?